vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and GAIA, INC (GAIA). Click either name above to swap in a different company.
GAIA, INC is the larger business by last-quarter revenue ($25.5M vs $19.2M, roughly 1.3× Apyx Medical Corp). GAIA, INC runs the higher net margin — -0.3% vs -6.8%, a 6.5% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 5.8%). GAIA, INC produced more free cash flow last quarter ($76.0K vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 9.4%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Gaia, Inc. is a publicly traded (NASDAQ:GAIA) American media company founded in 1988 by Jirka Rysavy in Louisville, Colorado. It owns and operates Gaia TV, a subscription video on-demand service consisting of original and licensed alternative media documentaries, including those on wellness, spirituality and conspiracy theories.
APYX vs GAIA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $25.5M |
| Net Profit | $-1.3M | $-75.0K |
| Gross Margin | 62.6% | 87.6% |
| Operating Margin | 0.1% | -2.6% |
| Net Margin | -6.8% | -0.3% |
| Revenue YoY | 34.7% | 5.8% |
| Net Profit YoY | 71.9% | 91.7% |
| EPS (diluted) | — | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $25.5M | ||
| Q3 25 | $12.9M | $25.0M | ||
| Q2 25 | $11.4M | $24.6M | ||
| Q1 25 | $9.4M | $23.8M | ||
| Q4 24 | $14.2M | $24.1M | ||
| Q3 24 | $11.5M | $22.0M | ||
| Q2 24 | $12.1M | $21.9M | ||
| Q1 24 | $10.2M | $21.3M |
| Q4 25 | $-1.3M | $-75.0K | ||
| Q3 25 | $-2.0M | $-1.2M | ||
| Q2 25 | $-3.8M | $-2.0M | ||
| Q1 25 | $-4.2M | $-1.2M | ||
| Q4 24 | $-4.6M | $-907.0K | ||
| Q3 24 | $-4.7M | $-1.2M | ||
| Q2 24 | $-6.6M | $-2.2M | ||
| Q1 24 | $-7.6M | $-971.0K |
| Q4 25 | 62.6% | 87.6% | ||
| Q3 25 | 64.4% | 86.4% | ||
| Q2 25 | 62.3% | 86.7% | ||
| Q1 25 | 60.1% | 87.7% | ||
| Q4 24 | 63.0% | 88.2% | ||
| Q3 24 | 60.5% | 86.1% | ||
| Q2 24 | 61.7% | 84.5% | ||
| Q1 24 | 58.1% | 85.3% |
| Q4 25 | 0.1% | -2.6% | ||
| Q3 25 | -6.5% | -5.0% | ||
| Q2 25 | -22.6% | -8.9% | ||
| Q1 25 | -32.4% | -4.3% | ||
| Q4 24 | -21.4% | -7.1% | ||
| Q3 24 | -31.6% | -5.3% | ||
| Q2 24 | -45.7% | -9.1% | ||
| Q1 24 | -64.6% | -4.0% |
| Q4 25 | -6.8% | -0.3% | ||
| Q3 25 | -15.4% | -4.6% | ||
| Q2 25 | -33.2% | -8.3% | ||
| Q1 25 | -44.0% | -5.1% | ||
| Q4 24 | -32.5% | -3.8% | ||
| Q3 24 | -40.9% | -5.4% | ||
| Q2 24 | -54.0% | -9.9% | ||
| Q1 24 | -74.0% | -4.6% |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $-0.03 | ||
| Q3 24 | — | $-0.05 | ||
| Q2 24 | $-0.19 | $-0.09 | ||
| Q1 24 | $-0.22 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $13.5M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $87.9M |
| Total Assets | $66.8M | $154.6M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $13.5M | ||
| Q3 25 | $25.1M | $14.2M | ||
| Q2 25 | $29.3M | $13.9M | ||
| Q1 25 | $31.0M | $13.1M | ||
| Q4 24 | $31.7M | $5.9M | ||
| Q3 24 | $28.0M | $4.4M | ||
| Q2 24 | $32.7M | $5.5M | ||
| Q1 24 | $37.3M | $8.6M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $87.9M | ||
| Q3 25 | $5.8M | $86.3M | ||
| Q2 25 | $7.3M | $85.7M | ||
| Q1 25 | $10.5M | $87.0M | ||
| Q4 24 | $14.2M | $80.7M | ||
| Q3 24 | $11.0M | $81.2M | ||
| Q2 24 | $14.7M | $82.1M | ||
| Q1 24 | $20.3M | $84.8M |
| Q4 25 | $66.8M | $154.6M | ||
| Q3 25 | $57.4M | $151.1M | ||
| Q2 25 | $58.2M | $147.0M | ||
| Q1 25 | $60.2M | $148.5M | ||
| Q4 24 | $64.8M | $141.2M | ||
| Q3 24 | $60.7M | $139.6M | ||
| Q2 24 | $65.4M | $142.1M | ||
| Q1 24 | $70.7M | $133.8M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $1.8M |
| Free Cash FlowOCF − Capex | $-2.8M | $76.0K |
| FCF MarginFCF / Revenue | -14.6% | 0.3% |
| Capex IntensityCapex / Revenue | 1.4% | 6.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $-377.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $1.8M | ||
| Q3 25 | $-3.5M | $326.0K | ||
| Q2 25 | $-1.2M | $2.3M | ||
| Q1 25 | $-702.0K | $1.3M | ||
| Q4 24 | $-2.9M | $2.7M | ||
| Q3 24 | $-4.4M | $409.0K | ||
| Q2 24 | $-4.3M | $-2.1M | ||
| Q1 24 | $-6.3M | $5.9M |
| Q4 25 | $-2.8M | $76.0K | ||
| Q3 25 | $-4.1M | $-1.6M | ||
| Q2 25 | $-1.5M | $880.0K | ||
| Q1 25 | $-757.0K | $268.0K | ||
| Q4 24 | $-3.2M | $1.6M | ||
| Q3 24 | $-4.6M | $-952.0K | ||
| Q2 24 | $-4.6M | $-3.5M | ||
| Q1 24 | $-6.4M | $4.9M |
| Q4 25 | -14.6% | 0.3% | ||
| Q3 25 | -31.5% | -6.4% | ||
| Q2 25 | -13.2% | 3.6% | ||
| Q1 25 | -8.0% | 1.1% | ||
| Q4 24 | -22.4% | 6.5% | ||
| Q3 24 | -40.0% | -4.3% | ||
| Q2 24 | -38.0% | -16.1% | ||
| Q1 24 | -62.2% | 22.8% |
| Q4 25 | 1.4% | 6.6% | ||
| Q3 25 | 4.0% | 7.7% | ||
| Q2 25 | 2.3% | 5.7% | ||
| Q1 25 | 0.6% | 4.3% | ||
| Q4 24 | 1.7% | 4.6% | ||
| Q3 24 | 1.3% | 6.2% | ||
| Q2 24 | 2.4% | 6.6% | ||
| Q1 24 | 0.3% | 5.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APYX
Segment breakdown not available.
GAIA
| US | $16.7M | 65% |
| Non Us | $8.8M | 35% |
